A blood marker of inflammation called lymphocyte-to-monocyte ratio (LMR) is an independent predictor of liver recompensation — when liver function improves with treatment despite permanent scarring — in people with primary biliary cholangitis (PBC). That’s according to a new study from researchers in China that showed that higher blood LMR levels — denoting a less active […] The post Blood marker can predict liver function improvement in PBC appeared first on Liver Disease News.
